Karen Finnerman one of the Fast Money panelists/fund managers has ARWR with a spec buy and a $45 target. She thinks this could be a target of a big cap bio also.
I have been patient on this one….hoping its another DNDN or IMCL that worked out well for me several years ago. Wish I owned more but my rule on bios is less core position and keep trading it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.